Kanika Sehgal, MBBS: The State of C Difficile Care


There are several potential treatments on the horizon for C difficile infections.

The state of care for C difficile infections is improving rapidly by the day.

Fecal microbiota transplantation (FMT), live microbiome therapeutics (LMT), and new antibiotics have drastically led to improving care.

And a lot of the measures put in place during the COVID-19 pandemic has led to a drop in hospital-acquired infections.

With the state of care improving, new research suggests C difficile cases are not related to an increased risk of emotional distress for patients.

In an interview with HCPLive®, Kanika Sehgal, MBBS, Research Fellow at Mayo Clinic Rochester, explained the current state of C difficile care.

Sehgal recently presented data at 2022 Digestive Disease Week Annual Meeting in San Diego, on the psychological distress in patients at the time of symptom development for CDI.

In the study, the investigators examined adult patients with an index episode of CDI, no history of irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD).

All 8 patients developed abdominal pain that was present for at least 1 day per week and was related to change in bowel movement consistency and frequency.

Related Videos
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
Ghada Bourjeily, MD: Research Gaps on Sleep Issues During Pregnancy
John Winkelman, MD, PhD: When to Use Low-Dose Opioids for Restless Legs Syndrome
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
© 2024 MJH Life Sciences

All rights reserved.